Kenvue: The Quiet Colossus Monetizing Your Headache, One Continent at a Time
From the Shard to São Paulo, a quiet corporate ghost has been flitting through medicine cabinets and quarterly earnings calls: Kenvue, the Johnson & Johnson spin-off that now owns everything from Tylenol to the sticky little BAND-AID you applied last week while pretending your kitchen knife skills were better than they are. In 2023, the…